PEMBROKE,
Non-GAAP operating loss(5) was
Maiden's book value per common share(1) was
Commenting on the fourth quarter of 2019 financial results,
Re-Domestication of
Effective
Consolidated Results for the Quarter Ended
Net loss attributable to Maiden common shareholders for the three months ended
-
net loss from continuing operations of
$21.0 million in the fourth quarter of 2019 compared to$216.7 million for the same period in 2018, largely due to the following:-
an underwriting loss(4) of
$21.7 million in the fourth quarter of 2019 compared to$232.3 million in the same period in 2018. The reduction in the underwriting loss was due to lower adverse prior year loss development incurred, primarily within the AmTrust Reinsurance segment, of$16.1 million in the fourth quarter of 2019 compared to adverse prior year loss development of$152.8 million during the same period in 2018; -
realized gains on investment of
$2.2 million for the three months endedDecember 31, 2019 compared to realized losses of$1.2 million for the same period in 2018; and -
other general and administrative expenses decreased to
$6.8 million for the three months endedDecember 31, 2019 compared to$10.2 million for the same period in 2018 due to lower salary, benefits and other corporate expenses associated with the Strategic Review and related headcount reductions since late 2018.
-
an underwriting loss(4) of
-
net loss from discontinued operations of
$0.5 million compared to net loss from discontinued operations of$52.5 million for the same period in 2018; the prior year results were primarily due to the realized loss recognized on the disposal of our wholly-owned subsidiaryMaiden Reinsurance North America, Inc. (“Maiden US”). The 2018 loss also included recognition of unrealized losses on investments in Maiden US of$26.6 million .
In the fourth quarter of 2019, gross premiums written were
During the fourth quarter of 2019, net investment income decreased to
During the fourth quarter of 2019, net loss and loss adjustment expenses decreased to
Commission and other acquisition expenses decreased to
General and administrative expenses for the fourth quarter of 2019 decreased to
Consolidated Results for the Year Ended
Net loss attributable to Maiden common shareholders for the year ended
-
net loss from continuing operations of
$109.4 million compared to$450.3 million for the same period in 2018 largely due to the following:-
an underwriting loss of
$183.8 million compared to$520.2 million for the same period in 2018. The reduction in the underwriting loss was principally due to the impact of:-
lower adverse prior year loss development incurred, primarily within the AmTrust Reinsurance segment, of
$112.5 million for the year endedDecember 31, 2019 compared to$403.2 million during the same period in 2018; partly offset by - higher initial losses incurred on current year premiums earned during the period within the AmTrust Reinsurance segment which excludes the terminated business under the Partial Termination Amendment (the "Terminated Business"); and
-
higher ceding commission payable which increased by five percentage points, or
$18.7 million , for the remaining in-force business immediately prior toJanuary 1, 2019 (excluding Terminated Business) and related unearned premium as ofJanuary 1, 2019 under the Partial Termination Amendment with AmTrust.
-
lower adverse prior year loss development incurred, primarily within the AmTrust Reinsurance segment, of
-
realized gains on investment of
$27.9 million for the year endedDecember 31, 2019 compared to realized losses of$1.5 million for the same period in 2018; and -
no dividends were paid to preference shareholders for the year ended
December 31, 2019 compared to$25.6 million for the same period in 2018. Our Board of Directors did not declare dividends on any of our preference shares during 2019.
-
an underwriting loss of
-
net loss from discontinued operations of
$22.5 million compared to net loss from discontinued operations of$94.1 million for the same period in 2018 largely as a result of the Settlement and Commutation Agreement entered into between Maiden and Enstar onJuly 31, 2019 which caused a net additional loss of$16.7 million to be recognized. The 2018 results included the impairment of goodwill and intangible assets of$74.2 million that was recognized due to the sale of Maiden US, partly offset by the proceeds of the sale of the Renewal Rights (as defined in our Annual Report on Form 10-K filed with theSEC today) of$7.5 million .
During the year ended
During the year ended
Realized gains of
During the year ended
Commission and other acquisition expenses decreased to
General and administrative expenses for the year ended
LPT/ADC Agreement with Enstar
Pursuant to the LPT/ADC Agreement, Enstar's
Cumulative ceded losses exceeding
Amortization of the deferred gain will not occur until paid losses have exceeded the minimum retention under the LPT/ADC Agreement. The current payout date for the losses covered by the LPT/ADC Agreement before the minimum retention is exceeded is expected to be during 2024.
Non-GAAP Operating Results for the Three and Twelve Months Ended
Non-GAAP operating loss was
In addition to other adjustments, management has adjusted the GAAP net operating loss and underwriting results by recognizing the unamortized deferred gain arising from the LPT/ADC Agreement which is fully recoverable from Cavello to show the ultimate economic benefit of the LPT/ADC Agreement to Maiden. The amount recognized as an unamortized deferred gain liability for the three and twelve months ended
For the three and twelve months ended
The improvement in the non-GAAP operating losses for the three and twelve months ended
Report on Form 10-K for the Year Ended
The Company’s Annual Report on Form 10-K for the year ended
Total assets were
The Company has discontinued the presentation of certain non-GAAP measures such as combined ratio and its related components in this news release, as it believes that as the run-off of its reinsurance portfolios progresses, such ratios are increasingly not meaningful and of less value to readers as they evaluate the financial results of the Company. The Company has, for the time being, continued to utilize such non-GAAP measures on an annual basis in its Annual Report on Form 10-K for the year ended
Quarterly Dividends
The Company's Board of Directors did not authorize any quarterly dividends related to either its common shares or any series of its preferred shares. At
About
Special Note about Forward-Looking Statements
Certain statements in this press release, other than purely historical information, including estimates, projections, statements relating to the Company’s business plans, objectives and expected operating results and the assumptions upon which those statements are based are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include general statements both with respect to the Company and the insurance industry and generally are identified with the words "anticipate", "believe", "expect", "predict", "estimate", "intend", "plan", "project", "seek", "potential", "possible", "could", "might", "may", "should", "will", "would", "will be", "will continue", "will likely result" and similar expressions. In light of the risks and uncertainties inherent in all forward-looking statements, the inclusion of such statements in this press release should not be considered as a representation by the Company or any other person that the Company’s objectives or plans or other matters described in any forward-looking statement will be achieved. These statements are based on current plans, estimates, assumptions and expectations. Actual results may differ materially from those projected in such forward-looking statements and therefore, you should not place undue reliance on them. Important factors that could cause actual results to differ materially from those in such forward-looking statements are set forth in Item 1A "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended
The Company cautions that the list of important risk factors in its Annual Report on Form 10-K for the year ended
|
Consolidated Balance Sheets |
(in thousands (000's), except per share data) |
|
|
|
|||
|
|
||||
Assets |
|||||
Fixed maturities, available-for-sale, at fair value (amortized cost 2019: |
$ |
1,835,518 |
$ |
3,051,568 |
|
Fixed maturities, held-to-maturity, at amortized cost (fair value 2018: |
- |
1,015,681 |
|||
Other investments |
|
31,748 |
|
23,716 |
|
Total investments |
1,867,266 |
4,090,965 |
|||
Cash and cash equivalents |
48,197 |
200,841 |
|||
Restricted cash and cash equivalents |
59,081 |
130,148 |
|||
Accrued investment income |
18,331 |
27,824 |
|||
Reinsurance balances receivable, net |
12,181 |
67,997 |
|||
Reinsurance recoverable on unpaid losses |
623,422 |
71,901 |
|||
Loan to related party |
167,975 |
167,975 |
|||
Deferred commission and other acquisition expenses, net |
77,356 |
388,442 |
|||
Funds withheld receivable |
684,441 |
27,039 |
|||
Other assets |
9,946 |
10,700 |
|||
Assets held for sale |
|
- |
|
103,628 |
|
Total Assets |
$ |
3,568,196 |
$ |
5,287,460 |
|
Liabilities and Equity |
|||||
Liabilities |
|||||
Reserve for loss and loss adjustment expenses |
$ |
2,439,907 |
$ |
3,126,134 |
|
Unearned premiums |
220,269 |
1,200,419 |
|||
Deferred gain on retroactive reinsurance |
112,950 |
- |
|||
Accrued expenses and other liabilities |
32,444 |
66,183 |
|||
Senior notes - principal amount |
262,500 |
262,500 |
|||
Less: unamortized debt issuance costs |
|
7,592 |
|
7,806 |
|
Senior notes, net |
|
254,908 |
|
254,694 |
|
Liabilities held for sale |
|
- |
|
85,114 |
|
Total Liabilities |
|
3,060,478 |
|
4,732,544 |
|
Commitments and Contingencies |
|||||
Equity |
|||||
Preference Shares |
465,000 |
465,000 |
|||
Common shares |
882 |
879 |
|||
Additional paid-in capital |
751,327 |
749,418 |
|||
Accumulated other comprehensive income (loss) |
17,836 |
(65,616) |
|||
Accumulated deficit |
(695,794) |
(563,891) |
|||
|
|
(31,533) |
|
(31,515) |
|
Total Maiden Shareholders’ Equity |
507,718 |
554,275 |
|||
Noncontrolling interest in subsidiaries |
|
- |
|
641 |
|
Total Equity |
|
507,718 |
|
554,916 |
|
Total Liabilities and Equity |
$ |
3,568,196 |
$ |
5,287,460 |
|
Book value per common share(1) |
$ |
0.51 |
$ |
1.08 |
|
Common shares outstanding |
83,148,458 |
82,948,577 |
|
|||||||||||
Consolidated Statements of Income |
|||||||||||
(in thousands (000's), except per share data) |
|||||||||||
For the Three Months Ended
|
|
For the Year Ended
|
|||||||||
2019 |
|
2018 |
|
2019 |
|
2018 |
|||||
Revenues: |
|||||||||||
Gross premiums written |
$ |
(5,415) |
$ |
388,451 |
$ |
(528,593) |
$ |
2,017,798 |
|||
Net premiums written |
$ |
(5,855) |
$ |
388,112 |
$ |
(531,850) |
$ |
2,014,597 |
|||
Change in unearned premiums |
|
41,631 |
|
96,812 |
|
979,612 |
|
11,605 |
|||
Net premiums earned |
35,776 |
484,924 |
447,762 |
2,026,202 |
|||||||
Other insurance revenue |
721 |
2,052 |
2,841 |
9,681 |
|||||||
Net investment income |
21,470 |
34,737 |
97,837 |
136,285 |
|||||||
Net realized gains (losses) on investment |
2,175 |
(1,247) |
27,860 |
(1,529) |
|||||||
Total other-than-temporary impairment losses |
- |
(5,353) |
(165) |
(5,832) |
|||||||
Portion of loss recognized in other comprehensive income (loss) |
|
- |
|
- |
|
- |
|
- |
|||
Net impairment losses recognized in earnings |
|
- |
|
(5,353) |
|
(165) |
|
(5,832) |
|||
Total revenues |
|
60,142 |
|
515,113 |
|
576,135 |
|
2,164,807 |
|||
Expenses: |
|||||||||||
Net loss and loss adjustment expenses |
37,719 |
556,618 |
452,829 |
1,880,121 |
|||||||
Commission and other acquisition expenses |
17,724 |
157,714 |
169,760 |
654,740 |
|||||||
General and administrative expenses |
|
9,543 |
|
15,202 |
|
47,218 |
|
64,940 |
|||
Total expenses |
|
64,986 |
|
729,534 |
|
669,807 |
|
2,599,801 |
|||
Other expenses: |
|||||||||||
Interest and amortization expenses |
(4,830) |
(4,831) |
(19,320) |
(19,318) |
|||||||
Foreign exchange and other (losses) gains |
|
(11,294) |
|
2,599 |
|
2,719 |
|
4,461 |
|||
Total other expenses |
|
(16,124) |
|
(2,232) |
|
(16,601) |
|
(14,857) |
|||
Loss before income taxes |
(20,968) |
(216,653) |
(110,273) |
(449,851) |
|||||||
Less: income tax expense (benefit) |
|
66 |
|
39 |
|
(911) |
|
441 |
|||
Net loss from continuing operations |
(21,034) |
(216,692) |
(109,362) |
(450,292) |
|||||||
Loss from discontinued operations, net of income tax |
|
(493) |
|
(52,504) |
|
(22,541) |
|
(94,113) |
|||
Net loss |
(21,527) |
(269,196) |
(131,903) |
(544,405) |
|||||||
Net income attributable to noncontrolling interests |
|
- |
|
(39) |
|
- |
|
(219) |
|||
Net loss attributable to Maiden |
(21,527) |
(269,235) |
(131,903) |
(544,624) |
|||||||
Dividends on preference shares(2) |
|
- |
|
- |
|
- |
|
(25,636) |
|||
Net loss attributable to Maiden common shareholders |
$ |
(21,527) |
$ |
(269,235) |
$ |
(131,903) |
$ |
(570,260) |
|||
Basic and diluted loss from continuing operations per share attributable to Maiden common shareholders(9) |
$ |
(0.25) |
$ |
(2.61) |
$ |
(1.32) |
$ |
(5.74) |
|||
Basic and diluted loss from discontinued operations per share attributable to Maiden common shareholders(9) |
|
(0.01) |
|
(0.64) |
|
(0.27) |
|
(1.13) |
|||
Basic and diluted loss per share attributable to Maiden common shareholders(9) |
$ |
(0.26) |
$ |
(3.25) |
$ |
(1.59) |
$ |
(6.87) |
|||
Dividends declared per common share |
$ |
- |
$ |
- |
$ |
- |
$ |
0.35 |
|||
Annualized return on average common equity |
-154.1% |
-538.3% |
-199.9% |
-133.2% |
|||||||
Weighted average number of common shares - basic and diluted(9) |
83,133,466 |
82,946,266 |
83,061,259 |
83,050,362 |
|
Supplemental Financial Data - Segment Information |
(in thousands (000's)) |
For the Three Months Ended |
Diversified
|
AmTrust
|
Other |
Total |
|||||||||||
Gross premiums written |
$ |
11,387 |
$ |
(16,802) |
$ |
- |
$ |
(5,415) |
|||||||
Net premiums written |
$ |
10,947 |
$ |
(16,802) |
$ |
- |
$ |
(5,855) |
|||||||
Net premiums earned |
$ |
15,435 |
$ |
20,341 |
$ |
- |
$ |
35,776 |
|||||||
Other insurance revenue |
721 |
- |
- |
721 |
|||||||||||
Net loss and loss adjustment expenses ("loss and LAE") |
(9,210) |
(28,509) |
- |
(37,719) |
|||||||||||
Commissions and other acquisition expenses |
(5,485) |
(12,239) |
- |
(17,724) |
|||||||||||
General and administrative expenses(3) |
|
(1,900) |
|
(832) |
|
- |
|
(2,732) |
|||||||
Underwriting loss(4) |
$ |
(439) |
$ |
(21,239) |
$ |
- |
$ |
(21,678) |
|||||||
Reconciliation to net loss from continuing operations |
|||||||||||||||
Net investment income and realized gains on investment |
23,645 |
||||||||||||||
Interest and amortization expenses |
(4,830) |
||||||||||||||
Foreign exchange and other losses |
(11,294) |
||||||||||||||
Other general and administrative expenses(3) |
(6,811) |
||||||||||||||
Income tax expense |
|
(66) |
|||||||||||||
Net loss from continuing operations |
$ |
(21,034) |
|||||||||||||
For the Three Months Ended |
Diversified
|
AmTrust
|
Other |
Total |
|||||||||||
Gross premiums written |
$ |
20,379 |
$ |
368,072 |
$ |
- |
$ |
388,451 |
|||||||
Net premiums written |
$ |
20,040 |
$ |
368,072 |
$ |
- |
$ |
388,112 |
|||||||
Net premiums earned |
$ |
29,649 |
$ |
455,275 |
$ |
- |
$ |
484,924 |
|||||||
Other insurance revenue |
2,052 |
- |
- |
2,052 |
|||||||||||
Net loss and LAE |
(19,613) |
(536,689) |
(316) |
(556,618) |
|||||||||||
Commissions and other acquisition expenses |
(10,488) |
(147,226) |
- |
(157,714) |
|||||||||||
General and administrative expenses(3) |
|
(4,066) |
|
(891) |
|
- |
|
(4,957) |
|||||||
Underwriting loss(4) |
$ |
(2,466) |
$ |
(229,531) |
$ |
(316) |
$ |
(232,313) |
|||||||
Reconciliation to net loss from continuing operations |
|||||||||||||||
Net investment income and realized losses on investment |
33,490 |
||||||||||||||
Total other-than-temporary impairment losses |
(5,353) |
||||||||||||||
Interest and amortization expenses |
(4,831) |
||||||||||||||
Foreign exchange and other gains |
2,599 |
||||||||||||||
Other general and administrative expenses(3) |
(10,245) |
||||||||||||||
Income tax expense |
|
(39) |
|||||||||||||
Net loss from continuing operations |
$ |
(216,692) |
|
|||||||||||||||
Supplemental Financial Data - Segment Information |
|||||||||||||||
(in thousands (000's)) |
|||||||||||||||
For the Year Ended |
Diversified
|
AmTrust
|
Other |
Total |
|||||||||||
Gross premiums written |
$ |
52,408 |
$ |
(581,001) |
$ |
- |
$ |
(528,593) |
|||||||
Net premiums written |
$ |
49,151 |
$ |
(581,001) |
$ |
- |
$ |
(531,850) |
|||||||
Net premiums earned |
$ |
83,691 |
$ |
364,071 |
$ |
- |
$ |
447,762 |
|||||||
Other insurance revenue |
2,841 |
- |
- |
2,841 |
|||||||||||
Net loss and LAE |
(49,905) |
(402,612) |
(312) |
(452,829) |
|||||||||||
Commissions and other acquisition expenses |
(29,898) |
(139,862) |
- |
(169,760) |
|||||||||||
General and administrative expenses(3) |
|
(8,872) |
|
(2,895) |
|
- |
|
(11,767) |
|||||||
Underwriting loss(4) |
$ |
(2,143) |
$ |
(181,298) |
$ |
(312) |
$ |
(183,753) |
|||||||
Reconciliation to net loss from continuing operations |
|||||||||||||||
Net investment income and realized gains on investment |
125,697 |
||||||||||||||
Total other-than-temporary impairment losses |
(165) |
||||||||||||||
Interest and amortization expenses |
(19,320) |
||||||||||||||
Foreign exchange and other gains |
2,719 |
||||||||||||||
Other general and administrative expenses(3) |
(35,451) |
||||||||||||||
Income tax benefit |
|
911 |
|||||||||||||
Net loss from continuing operations |
$ |
(109,362) |
|||||||||||||
|
|||||||||||||||
For the Year Ended |
Diversified
|
AmTrust
|
Other |
Total |
|||||||||||
Gross premiums written |
$ |
131,518 |
$ |
1,886,280 |
$ |
- |
$ |
2,017,798 |
|||||||
Net premiums written |
$ |
129,319 |
$ |
1,885,278 |
$ |
- |
$ |
2,014,597 |
|||||||
Net premiums earned |
$ |
112,487 |
$ |
1,913,715 |
$ |
- |
$ |
2,026,202 |
|||||||
Other insurance revenue |
9,681 |
- |
- |
9,681 |
|||||||||||
Net loss and LAE |
(71,441) |
(1,806,995) |
(1,685) |
(1,880,121) |
|||||||||||
Commissions and other acquisition expenses |
(38,749) |
(615,991) |
- |
(654,740) |
|||||||||||
General and administrative expenses(3) |
|
(17,396) |
|
(3,845) |
|
- |
|
(21,241) |
|||||||
Underwriting loss(4) |
$ |
(5,418) |
$ |
(513,116) |
$ |
(1,685) |
$ |
(520,219) |
|||||||
Reconciliation to net loss from continuing operations |
|||||||||||||||
Net investment income and realized losses on investment |
134,756 |
||||||||||||||
Total other-than-temporary impairment losses |
(5,832) |
||||||||||||||
Interest and amortization expenses |
(19,318) |
||||||||||||||
Foreign exchange and other gains |
4,461 |
||||||||||||||
Other general and administrative expenses(3) |
(43,699) |
||||||||||||||
Income tax expense |
|
(441) |
|||||||||||||
Net loss from continuing operations |
$ |
(450,292) |
|
|||||||||||
Non - GAAP Financial Measures |
|||||||||||
(in thousands (000's), except per share data) |
|||||||||||
For the Three Months Ended
|
|
For the Year Ended
|
|||||||||
2019 |
|
2018 |
|
2019 |
|
2018 |
|||||
Non-GAAP operating loss attributable to Maiden common shareholders(5) |
$ |
(3,507) |
$ |
(212,414) |
$ |
(26,514) |
$ |
(466,062) |
|||
Non-GAAP basic and diluted operating loss per share attributable to Maiden common shareholders |
$ |
(0.04) |
$ |
(2.56) |
$ |
(0.32) |
$ |
(5.61) |
|||
Annualized non-GAAP operating return on average common equity(6) |
-25.1% |
-424.7% |
-40.2% |
-108.8% |
|||||||
Reconciliation of net loss attributable to Maiden common shareholders to non-GAAP operating loss attributable to Maiden common shareholders: |
|||||||||||
Net loss attributable to Maiden common shareholders |
$ |
(21,527) |
$ |
(269,235) |
$ |
(131,903) |
$ |
(570,260) |
|||
Add (subtract) |
|||||||||||
Net realized (gains) losses on investment |
(2,175) |
1,247 |
(27,860) |
1,529 |
|||||||
Total other-than-temporary impairment losses |
- |
5,353 |
165 |
5,832 |
|||||||
Foreign exchange and other losses (gains) |
11,294 |
(2,599) |
(2,719) |
(4,461) |
|||||||
Loss from discontinued operations, net of income tax |
493 |
52,504 |
22,541 |
94,113 |
|||||||
Loss from NGHC Quota Share run-off |
- |
316 |
312 |
1,685 |
|||||||
Separation costs incurred due to retirement of former CEO and CFO |
- |
- |
- |
5,500 |
|||||||
Unamortized deferred gain on retroactive reinsurance |
8,408 |
- |
112,950 |
- |
|||||||
Non-GAAP operating loss attributable to Maiden common shareholders(5) |
$ |
(3,507) |
$ |
(212,414) |
$ |
(26,514) |
$ |
(466,062) |
|||
Weighted average number of common shares - basic and diluted |
83,133,466 |
82,946,266 |
83,061,259 |
83,050,362 |
|||||||
Reconciliation of diluted loss per share attributable to Maiden common shareholders to non-GAAP diluted operating loss per share attributable to Maiden common shareholders: |
|||||||||||
Diluted loss per share attributable to Maiden common shareholders |
$ |
(0.26) |
$ |
(3.25) |
$ |
(1.59) |
$ |
(6.87) |
|||
Add (subtract) |
|||||||||||
Net realized (gains) losses on investment |
(0.03) |
0.02 |
(0.34) |
0.02 |
|||||||
Total other-than-temporary impairment losses |
- |
0.07 |
- |
0.07 |
|||||||
Foreign exchange and other losses (gains) |
0.14 |
(0.03) |
(0.03) |
(0.05) |
|||||||
Loss from discontinued operations, net of income tax |
0.01 |
0.63 |
0.27 |
1.13 |
|||||||
Loss from NGHC Quota Share run-off |
- |
- |
0.01 |
0.02 |
|||||||
Separation costs incurred due to retirement of former CEO and CFO |
- |
- |
- |
0.07 |
|||||||
Unamortized deferred gain on retroactive reinsurance |
0.10 |
- |
1.36 |
- |
|||||||
Non-GAAP diluted operating loss per share attributable to Maiden common shareholders |
$ |
(0.04) |
$ |
(2.56) |
$ |
(0.32) |
$ |
(5.61) |
|||
|
|
||||||||||
Reconciliation of total Maiden shareholders' equity to adjusted Maiden shareholders' equity: |
|||||||||||
Total Maiden Shareholders’ Equity |
$ |
507,718 |
$ |
554,275 |
|||||||
Unamortized deferred gain on retroactive reinsurance |
112,950 |
- |
|||||||||
Adjusted Maiden shareholders' equity(10) |
$ |
620,668 |
$ |
554,275 |
|||||||
Reconciliation of book value per common share to adjusted book value per common share: |
|||||||||||
Book value per common share |
$ |
0.51 |
$ |
1.08 |
|||||||
Unamortized deferred gain on retroactive reinsurance |
1.36 |
- |
|||||||||
Adjusted book value per common share(10) |
$ |
1.87 |
$ |
1.08 |
|||||||
For the Three Months Ended
|
|
For the Year Ended
|
|||||||||
Non-GAAP underwriting results: |
2019 |
|
2018 |
|
2019 |
|
2018 |
||||
Gross premiums written |
$ |
(5,415) |
$ |
388,451 |
$ |
(528,593) |
$ |
2,017,798 |
|||
Net premiums written |
$ |
(5,855) |
$ |
388,112 |
$ |
(531,850) |
$ |
2,014,597 |
|||
Net premiums earned |
$ |
35,776 |
$ |
484,924 |
$ |
447,762 |
$ |
2,026,202 |
|||
Other insurance revenue |
721 |
2,052 |
2,841 |
9,681 |
|||||||
Non-GAAP net loss and LAE(11) |
(29,311) |
(556,618) |
(339,879) |
(1,880,121) |
|||||||
Commissions and other acquisition expenses |
(17,724) |
(157,714) |
(169,760) |
(654,740) |
|||||||
General and administrative expenses(3) |
(2,732) |
(4,957) |
(11,767) |
(21,241) |
|||||||
Non-GAAP underwriting loss(11) |
$ |
(13,270) |
$ |
(232,313) |
$ |
(70,803) |
$ |
(520,219) |
|||
Non-GAAP net loss and LAE: |
|||||||||||
Net loss and LAE |
$ |
37,719 |
$ |
556,618 |
$ |
452,829 |
$ |
1,880,121 |
|||
Less: Unamortized deferred gain on retroactive reinsurance |
8,408 |
- |
112,950 |
- |
|||||||
Non-GAAP net loss and LAE(11) |
$ |
29,311 |
$ |
556,618 |
$ |
339,879 |
$ |
1,880,121 |
|
|||||
Non - GAAP Financial Measures |
|||||
(in thousands (000's), except per share data) |
|||||
|
|
||||
Investable assets: |
|||||
Total investments |
$ |
1,867,266 |
$ |
4,090,965 |
|
Cash and cash equivalents |
|
48,197 |
|
200,841 |
|
Restricted cash and cash equivalents |
|
59,081 |
|
130,148 |
|
Loan to related party |
|
167,975 |
|
167,975 |
|
Funds withheld receivable |
|
684,441 |
|
27,039 |
|
Total investable assets(7) |
$ |
2,826,960 |
$ |
4,616,968 |
|
|
|||||
|
|
||||
Capital: |
|
||||
Preference shares |
$ |
465,000 |
$ |
465,000 |
|
Common shareholders' equity |
|
42,718 |
|
89,275 |
|
Total Maiden shareholders' equity |
|
507,718 |
|
554,275 |
|
2016 Senior Notes |
|
110,000 |
|
110,000 |
|
2013 Senior Notes |
|
152,500 |
|
152,500 |
|
Total capital resources(8) |
$ |
770,218 |
$ |
816,775 |
|
(1) Book value per common share is calculated using Maiden common shareholders’ equity (shareholders' equity excluding the aggregate liquidation value of our preference shares) divided by the number of common shares outstanding. |
|||||
(2) Dividends on preference shares consist of |
|||||
(3) Underwriting related general and administrative expenses is a non-GAAP measure and includes expenses which are segregated for analytical purposes as a component of underwriting loss. |
|||||
(4) Underwriting loss is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities. Management believes that this measure is important in evaluating the underwriting performance of the Company and its segments. This measure is also a useful tool to measure the profitability of the Company separately from the investment results and is also a widely used performance indicator in the insurance industry. |
|||||
(5) Non-GAAP operating income (loss) is a non-GAAP financial measure defined by the Company as net (loss) income attributable to Maiden common shareholders excluding realized investment gains and losses, total other-than-temporary impairment losses, foreign exchange and other gains and losses, (loss) income from discontinued operations, net of income tax, income (loss) from NGHC Quota Share run-off, separation costs incurred due to retirement of former CEO and CFO and unamortized deferred gain on retroactive reinsurance and should not be considered as an alternative to net (loss) income. The Company's management believes that non-GAAP operating income (loss) is a useful indicator of trends in the Company's underlying operations. The Company's measure of non-GAAP operating income (loss) may not be comparable to similarly titled measures used by other companies. |
|||||
(6) Non-GAAP operating return on average common equity is a non-GAAP financial measure. Management uses non-GAAP operating return on average common shareholders' equity as a measure of profitability that focuses on the return to Maiden common shareholders. It is calculated using non-GAAP operating income (loss) attributable to Maiden common shareholders divided by average Maiden common shareholders' equity. |
|||||
(7) Investable assets is the total of the Company's investments, cash and cash equivalents, loan to a related party and funds withheld receivable. |
|||||
(8) Total capital resources is the sum of the Company's principal amount of debt and Maiden shareholders' equity. |
|||||
(9) During a period of loss, the basic weighted average common shares outstanding is used in the denominator of the diluted loss per common share computation as the effect of including potential dilutive shares would be anti-dilutive. |
|||||
(10) Adjusted Total Maiden Shareholders' Equity and Adjusted Book Value per Common Share: Management has adjusted GAAP Maiden shareholders' equity by adding the unamortized deferred gain on retroactive reinsurance arising from the LPT/ADC Agreement relating to losses incurred subject to that agreement to Maiden shareholders' equity. As a result, by virtue of this adjustment, management has also computed the Adjusted Book Value per Common Share. The deferred gain represents amounts fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement. We believe reflecting the economic benefit of this retroactive reinsurance agreement is helpful for understanding future trends in our operations, which will improve Maiden shareholders' equity over the settlement period. |
|||||
(11) Non-GAAP net loss and LAE and Non-GAAP underwriting income (loss): Management has further adjusted the net loss and LAE and underwriting income (loss) (as defined above) by recognizing into income the unamortized deferred gain arising from the LPT/ADC Agreement relating to losses subject to that agreement. The deferred gain represents amounts fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement on Maiden's underwriting income (loss). We believe reflecting the economic benefit of this retroactive reinsurance agreement is helpful for understanding future trends in our operations. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200318005779/en/
Maiden-SVC@sardverb.com
Source: